Stockreport

Gemphire Therapeutics Presents Data at American Heart Association (AHA) Scientific Sessions Showing that Gemcabene Significantly Reduces Atherogenic Remnant Lipoprotein and LDL-C as Add-on...

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
PDF Gemcabene reduced LDL-C by 20% and hsCRP by 53% when added to moderate intensity statin therapy In cardiometabolic patients gemcabene improves atherogenic burden and re [Read more]